153 related articles for article (PubMed ID: 22159832)
1. Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation: changes over the last decade.
Gosch M; Roth T; Kammerlander C; Joosten-Gstrein B; Benvenuti-Falger U; Blauth M; Lechleitner M
Z Gerontol Geriatr; 2011 Dec; 44(6):381-6. PubMed ID: 22159832
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study.
Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Wichrowska H; Napiórkowska L; Stuss M; Rozwandowicz A; Drozdzowska B
Endokrynol Pol; 2019; 70(6):473-477. PubMed ID: 31909456
[TBL] [Abstract][Full Text] [Related]
3. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
4. Secondary confounders of osteoporotic hip fractures in patients admitted to a geriatric acute care department.
Dovjak P; Föger-Samwald U; Konrad M; Bichler B; Pietschmann P
Z Gerontol Geriatr; 2015 Oct; 48(7):633-40. PubMed ID: 25421255
[TBL] [Abstract][Full Text] [Related]
5. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of osteoporosis in the oldest old.
Vandenbroucke A; Luyten FP; Flamaing J; Gielen E
Clin Interv Aging; 2017; 12():1065-1077. PubMed ID: 28740372
[TBL] [Abstract][Full Text] [Related]
7. Incidence and costs of osteoporosis-associated hip fractures in Austria.
Koeck CM; Schwappach DL; Niemann FM; Strassmann TJ; Ebner H; Klaushofer K
Wien Klin Wochenschr; 2001 May; 113(10):371-7. PubMed ID: 11432126
[TBL] [Abstract][Full Text] [Related]
8. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
9. Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
Brozek W; Reichardt B; Zwerina J; Dimai HP; Klaushofer K; Zwettler E
Osteoporos Int; 2016 Jan; 27(1):387-96. PubMed ID: 26576544
[TBL] [Abstract][Full Text] [Related]
10. Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough?
Kamel HK
J Clin Rheumatol; 2005 Apr; 11(2):68-71. PubMed ID: 16357705
[TBL] [Abstract][Full Text] [Related]
11. The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients.
Makridis KG; Karachalios T; Kontogeorgakos VA; Badras LS; Malizos KN
Injury; 2015 Feb; 46(2):378-83. PubMed ID: 25541417
[TBL] [Abstract][Full Text] [Related]
12. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
13. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
[TBL] [Abstract][Full Text] [Related]
14. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
[TBL] [Abstract][Full Text] [Related]
15. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
[TBL] [Abstract][Full Text] [Related]
16. Orthogeriatric co-management improves the outcome of long-term care residents with fragility fractures.
Gosch M; Hoffmann-Weltin Y; Roth T; Blauth M; Nicholas JA; Kammerlander C
Arch Orthop Trauma Surg; 2016 Oct; 136(10):1403-9. PubMed ID: 27501701
[TBL] [Abstract][Full Text] [Related]
17. Extensive undertreatment of osteoporosis in older Swedish women.
Lorentzon M; Nilsson AG; Johansson H; Kanis JA; Mellström D; Sundh D
Osteoporos Int; 2019 Jun; 30(6):1297-1305. PubMed ID: 30805678
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
[TBL] [Abstract][Full Text] [Related]
19. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
Roux C; Cooper C; Díez-Pérez A; Martinez L; Ortolani S; Gitlin M; Möller G; Shepherd S; Freemantle N
Osteoporos Int; 2011 Apr; 22(4):1227-36. PubMed ID: 20628731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
